Literature DB >> 22354089

Signalling through the grapevine.

Ivan Dikic1, Roger J Daly.   

Abstract

The 5th Barossa Meeting on 'Cell Signalling and Molecular Medicine' was held in November 2011 in the Barossa Valley, South Australia. The combination of an inspirational environment and outstanding science led to a superb meeting that highlighted the versatility of cellular signalling systems and how they can be targeted by novel therapeutic approaches.

Mesh：

Year:  2012        PMID： 22354089      PMCID： PMC3323131          DOI： 10.1038/embor.2012.16

Source DB:  PubMed          Journal:  EMBO Rep        ISSN： 1469-221X            Impact factor:   8.807


  9 in total

1.  What determines the specificity and outcomes of ubiquitin signaling?

Authors:  Fumiyo Ikeda; Nicola Crosetto; Ivan Dikic
Journal:  Cell       Date:  2010-11-24       Impact factor: 41.582

2.  Smac mimetics activate the E3 ligase activity of cIAP1 protein by promoting RING domain dimerization.

Authors:  Rebecca Feltham; Bodhi Bettjeman; Rhesa Budhidarmo; Peter D Mace; Sarah Shirley; Stephen M Condon; Srinivas K Chunduru; Mark A McKinlay; David L Vaux; John Silke; Catherine L Day
Journal:  J Biol Chem       Date:  2011-03-10       Impact factor: 5.157

3.  Phosphorylation of the autophagy receptor optineurin restricts Salmonella growth.

Authors:  Philipp Wild; Hesso Farhan; David G McEwan; Sebastian Wagner; Vladimir V Rogov; Nathan R Brady; Benjamin Richter; Jelena Korac; Oliver Waidmann; Chunaram Choudhary; Volker Dötsch; Dirk Bumann; Ivan Dikic
Journal:  Science       Date:  2011-05-26       Impact factor: 47.728

4.  USP1 deubiquitinates ID proteins to preserve a mesenchymal stem cell program in osteosarcoma.

Authors:  Samuel A Williams; Heather L Maecker; Dorothy M French; Jinfeng Liu; Andrew Gregg; Leah B Silverstein; Tim C Cao; Richard A D Carano; Vishva M Dixit
Journal:  Cell       Date:  2011-09-16       Impact factor: 41.582

5.  Linear ubiquitination prevents inflammation and regulates immune signalling.

Authors:  Björn Gerlach; Stefanie M Cordier; Anna C Schmukle; Christoph H Emmerich; Eva Rieser; Tobias L Haas; Andrew I Webb; James A Rickard; Holly Anderton; Wendy W-L Wong; Ueli Nachbur; Lahiru Gangoda; Uwe Warnken; Anthony W Purcell; John Silke; Henning Walczak
Journal:  Nature       Date:  2011-03-31       Impact factor: 49.962

6.  Targeting RNA polymerase I with an oral small molecule CX-5461 inhibits ribosomal RNA synthesis and solid tumor growth.

Authors:  Denis Drygin; Amy Lin; Josh Bliesath; Caroline B Ho; Sean E O'Brien; Chris Proffitt; Mayuko Omori; Mustapha Haddach; Michael K Schwaebe; Adam Siddiqui-Jain; Nicole Streiner; Jaclyn E Quin; Elaine Sanij; Megan J Bywater; Ross D Hannan; David Ryckman; Kenna Anderes; William G Rice
Journal:  Cancer Res       Date:  2010-12-15       Impact factor: 12.701

7.  MAVS forms functional prion-like aggregates to activate and propagate antiviral innate immune response.

Authors:  Fajian Hou; Lijun Sun; Hui Zheng; Brian Skaug; Qiu-Xing Jiang; Zhijian J Chen
Journal:  Cell       Date:  2011-07-21       Impact factor: 41.582

8.  Specific recognition of linear ubiquitin chains by NEMO is important for NF-kappaB activation.

Authors:  Simin Rahighi; Fumiyo Ikeda; Masato Kawasaki; Masato Akutsu; Nobuhiro Suzuki; Ryuichi Kato; Tobias Kensche; Tamami Uejima; Stuart Bloor; David Komander; Felix Randow; Soichi Wakatsuki; Ivan Dikic
Journal:  Cell       Date:  2009-03-20       Impact factor: 41.582

9.  Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2.

Authors:  Sergio E Alvarez; Kuzhuvelil B Harikumar; Nitai C Hait; Jeremy Allegood; Graham M Strub; Eugene Y Kim; Michael Maceyka; Hualiang Jiang; Cheng Luo; Tomasz Kordula; Sheldon Milstien; Sarah Spiegel
Journal:  Nature       Date:  2010-06-24       Impact factor: 49.962
  9 in total
  1 in total

1.  Network-Based Integration of Disparate Omic Data To Identify "Silent Players" in Cancer.

Authors:  Matthew Ruffalo; Mehmet Koyutürk; Roded Sharan
Journal:  PLoS Comput Biol       Date:  2015-12-18       Impact factor: 4.475
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.